Just recently, UMBC appointed biotech industry veteran Mark Schenerman as Graduate Program Director in Biotechnology, marking an important milestone for the program as it looks to move into a new phase of innovation and growth. Schenerman is an active UMBC biotech professor, runs his own biotech consulting business, and built an impressive biotech career that included more than two decades at MedImmune, one of the most important biotech companies in the region’s history.
Baltimore MedTech Sector a Key Asset for Ascending Biotech Cluster, Part One
Published on :BioBuzz has been reporting on myriad medtech university system spinouts and maturing companies from the Baltimore area for a number of years; we’ve featured a number of exciting and promising individual companies. However, as we’ve stepped back a bit to examine more recent Baltimore biohub developments, it’s become clear that there is an unmistakable groundswell of medtech activity that’s transforming the Baltimore life sciences sector.